Peter Sasieni
King's College London
StatisticsCancerInternal medicineObstetricsOncologyDemographyOdds ratioColposcopyCervical intraepithelial neoplasiaCervical cancerMEDLINECervical screeningPopulationGynecologyMass screeningMathematicsIncidence (epidemiology)Family medicineBreast cancerMedicine
360Publications
77H-index
15kCitations
Publications 356
Newest
#1Alejandra Castanon ('KCL': King's College London)H-Index: 17
#2Aruna Kamineni (KP: Kaiser Permanente)H-Index: 27
Last. Peter Sasieni ('KCL': King's College London)H-Index: 77
view all 5 authors...
The first step in evaluating the effectiveness of cervical screening is defining exposure to screening. Our aim was to describe the spectrum of screening exposure definitions used in studies of the effectiveness of cervical screening. This systematic review included case-control studies in a population-based screening setting. Outcome was incidence of cervical cancer. Three electronic databases were searched from 01/January/2012 to 06/December/2018. Articles prior to 2012 were identified from a ...
Source
#1Alejandra Castanon ('KCL': King's College London)H-Index: 17
#2Shama Sheikh ('KCL': King's College London)H-Index: 1
Last. Peter Sasieni ('KCL': King's College London)H-Index: 77
view all 4 authors...
BackgroundEnglish cervical screening programme guidelines changed between 2009 and 2012. We explore the impact on the age and intervals at which women receive a cytology test.MethodsEligible women ...
Source
#1Shuping J Li (QMUL: Queen Mary University of London)
#2Linda D. Sharples (Lond: University of London)H-Index: 73
Last. Stephen W. Duffy (QMUL: Queen Mary University of London)H-Index: 111
view all 7 authors...
ObjectivesThe National Health Service Bowel Cancer Screening Programme (NHS BCSP) in England has replaced guaiac faecal occult blood testing by faecal immunochemical testing (FIT). There is interes...
Source
#1Peter SasieniH-Index: 77
#2Peter HajekH-Index: 55
#1Nicholas Swart (UCL: University College London)H-Index: 3
#2Roberta Maroni ('KCL': King's College London)H-Index: 5
Last. Stephen Morris (University of Cambridge)H-Index: 71
view all 6 authors...
Abstract null null Background null Esophageal adenocarcinoma has a very poor prognosis unless detected early. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett esophagus, a precursor of esophageal adenocarcinoma. Randomised controlled trial data from the BEST3 trial has shown that an offer of Cytosponge-TFF3 in the primary care setting in England to individuals on medication for acid reflux increases detection of Barrett esophagus 10-fold over a year compared with stand...
Source
#1Francesca Pesola ('KCL': King's College London)H-Index: 15
#2Matejka Rebolj ('KCL': King's College London)H-Index: 26
Last. Peter Sasieni ('KCL': King's College London)H-Index: 77
view all 7 authors...
OBJECTIVE To determine the demand for colposcopy in the Cervical Screening Wales programme after the introduction of human papillomavirus (HPV) cervical screening, which coincided with the start of screening of women vaccinated against HPV types 16/18. DESIGN The study used a computational model that assigns screening and screening-related colposcopy events to birth cohorts in individual calendar years. SETTING Cervical Screening Wales. POPULATION Women aged 25-64 years from birth cohorts 1953-2...
Source
#1Rachael H. Dodd (USYD: University of Sydney)H-Index: 13
#3Fatjon Dekaj (ICH: UCL Institute of Child Health)
Last. Karly S. Louie (QMUL: Queen Mary University of London)H-Index: 15
view all 7 authors...
Awareness of the link between human papillomavirus (HPV) and oral cancer varies across populations. Levels of awareness and factors may impact HPV vaccine uptake in women and the intent to obtain the vaccine in men if it becomes available. A cross-sectional survey of 1415 UK university students (495 men and 920 women) aged 18-25 years was conducted. Women who had and had not received the HPV vaccine were included. Vaccination was not available for men at the time of the survey. Seventy percent o...
Source
#1A Castanon (Guy's Hospital)H-Index: 1
#2Leonardo I. Green (Guy's Hospital)
Last. Peter Sasieni (Guy's Hospital)H-Index: 77
view all 3 authors...
There is little empirical data on the absolute benefit of cervical screening between ages 60-64y on subsequent cancer risk. We estimate the incidence of cervical cancer up to age 84y in women with and without a cervical cytology test at age 60-64y, by screening histories aged 50-59y. The current study is a population based case-control study of women born between 1928 and 1956 and aged 60-84y between 2007 and 2018. We included all such women diagnosed with cervical cancer in England and an aged-...
Source
#1Jean-Pierre Laake (QMUL: Queen Mary University of London)H-Index: 3
#2Daniel Vulkan (QMUL: Queen Mary University of London)H-Index: 4
Last. Stephen W. Duffy (QMUL: Queen Mary University of London)H-Index: 111
view all 9 authors...
Abstract Background: For some common cancers, survival is lower in the UK than in comparable high-income countries. Aim: To assess the effectiveness of a targeted postal intervention (promoting awareness of cancer symptoms and earlier help-seeking) on patient consultation rates. Design and Setting: A two-arm randomised controlled trial (RCT) of adult patients registered at 23 general practices in England. Method: Adult patients who had not consulted their general practice in the previous 12 mont...
Source
#1Rebecca Landy (QMUL: Queen Mary University of London)H-Index: 15
#2Christopher Mathews ('KCL': King's College London)H-Index: 2
Last. Cosette M. Wheeler (UNM: University of New Mexico)H-Index: 91
view all 10 authors...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.